Fig. 3
From: Depleting TMED3 alleviates the development of endometrial carcinoma
Downstream molecular mechanism of TMED3 in ishikawa cells. A-B The comparison in expression levels of some apoptosis-related proteins mediated by TMED3 in the cell models (shCtrl vs. shTMED3). Each column is the mean value of the two gray values in the Human apoptosis antibody array. C Changes in some apoptosis-related proteins mediated by TMED3 detected by WB assay. D Changes in some TMED3-mediated proteins involved in PI3K/AKT and MAPK signaling pathways